A double-blind, controlled trial to evaluate the efficacy and safety of vitamin K1 ointment for cetuximab and Panitumumab-induced acneiform eruption
Ontology highlight
ABSTRACT: Interventions: 0.1% vitamin K1 ointment twice daily
Placebo ointment twice daily
Primary outcome(s): The number of acneiform eruptions of right and left lesions(face, neck, or chest) of the same patient before and after treatment
Study Design: Parallel Randomized
DISEASE(S): Colorectal Cancer
PROVIDER: 2623509 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA